TAQAs ADC to acquire Middle East drilling rigs of Schlumberger
Category: #headlines  By Mateen Dalal  Date: 2019-04-29
  • share
  • Twitter
  • Facebook
  • LinkedIn

TAQAs ADC to acquire Middle East drilling rigs of Schlumberger

The acquisition has followed on from fast-tracked expansion activity of ADC in 2018.

Saudi Arabia's Industrialisation and Energy Services Company (TAQA), has reportedly announced that Arabian Drilling Company (ADC), its drilling subsidiary, has agreed to acquire Middle East onshore drilling rig business of Schlumberger in Oman, Pakistan, Kuwait and Iraq for $415 million.

Reportedly, ADC will operate a fleet of 9 offshore rigs and 58 onshore rigs across MENA region. There will be over 5,900 employees in this combined firm.

The 2021 strategy of TAQA is aimed at becoming a leading regional oilfield services and equipment (OFSE) company. The 2021 strategy is based on three key pillars – supporting value by providing differentiated, best-in-class client services and safety, using the latest technologies; realizing better operational efficiencies and value by providing more integrated client services that are reliable, competitive and safe; and making value by growing into new markets and higher-tier services, and strengthening the position and growth of its existing businesses.

Azzam Shalabi, Chairman of the ADC board and CEO of TAQA, reportedly stated that the acquisition has been aligned with Saudi Vision 2030. It has positioned a leading Saudi company as a global player and leverages a more integrated regional approach to unlock value and drive growth across entire value chain, he further added.

As per reliable sources, the acquisition has followed on from fast-tracked expansion activity of ADC in 2018. The 16 rigs were commissioned to support the growth of Saudi Aramco in this activity. The transaction demonstrates that ADC and TAQA are delivering on growth strategies and transformation. It has also strengthened the partnership of Schlumberger and TAQA. TAQA has been looking forward to support ADC in the next phase of its expansion to benefit stakeholders.

The transaction is anticipated to be completed in the second half of 2019, subject to regulatory approvals.

For the record, Rothschild & Co. acted as exclusive financial advisor to Schlumberger and Moelis & Company acted as exclusive financial advisor to TAQA.

 

Source credit: https://www.oilandgasmiddleeast.com/drilling-production/33840-taqa-drilling-subsidiary-to-acquire-schlumbergers-middle-east-drilling-rigs-business-for-415mn

http://www.arabnews.com/node/1489376/corporate-news

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
By Mateen Dalal

Ambrx will receive additional development payments with Bristol-Meyers’ initiation of the Phase 1 clinical trial for Relaxin Ambrx Inc., a biopharmaceutical company focused on developing protein therapeutics, has recently announced that Bristo...

LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
By Mateen Dalal

The transaction will be LifeSpan BioSciences’ second investment this year following its Nordic-MUbio acquisition LifeSpan BioSciences (LSBio), a provider of life science research reagents and antibodies, has recently announced that it has acqu...

AbbVie buys Mavupharma to target STING pathway for cancer treatment
AbbVie buys Mavupharma to target STING pathway for cancer treatment
By Mateen Dalal

AbbVie Inc., a US-based pharmaceutical company recently announced acquisition of Mavupharma, a Seattle-based biopharmaceutical company, which is focused on innovative strategies to target the STimulator of INterferon Genes pathway for the treatment o...